Scarica l'app Stockscreener
10.29
0.39%
0.04
Precedente Chiudi:
$10.25
Aprire:
$10.23
Volume 24 ore:
1.59M
Relative Volume:
0.99
Capitalizzazione di mercato:
$3.23B
Reddito:
$2.68B
Utile/perdita netta:
$-184.45M
Rapporto P/E:
-15.12
EPS:
-0.6805
Flusso di cassa netto:
$229.23M
1 W Prestazione:
+0.00%
1M Prestazione:
+5.54%
6M Prestazione:
+35.04%
1 anno Prestazione:
+20.49%
Intervallo 1D:
$10.13
$10.45
Intervallo di 1 settimana:
$10.13
$10.62
Portata 52W:
$6.685
$10.68
Amneal Pharmaceuticals Inc Stock (AMRX) Company Profile
Nome
Amneal Pharmaceuticals Inc
Settore
Telefono
908-947-3120
Indirizzo
400 Crossing Boulevard, 3rd Floor, Bridgewater
Confronta AMRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AMRX
Amneal Pharmaceuticals Inc
|
10.29 | 3.22B | 2.68B | -184.45M | 229.23M | -0.6805 |
|
ZTS
Zoetis Inc
|
145.41 | 65.38B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.10 | 44.75B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.12 | 40.97B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.78 | 22.50B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
415.34 | 19.04B | 3.08B | 1.24B | 1.07B | 25.61 |
Amneal Pharmaceuticals Inc Stock (AMRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-06 | Iniziato | Goldman | Buy |
| 2025-02-24 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2024-09-06 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2021-04-07 | Ripresa | RBC Capital Mkts | Sector Perform |
| 2021-03-08 | Aggiornamento | Goldman | Sell → Buy |
| 2020-12-14 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2020-12-14 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-07-27 | Iniziato | Goldman | Sell |
| 2020-05-12 | Aggiornamento | Guggenheim | Sell → Neutral |
| 2019-12-12 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2019-11-12 | Downgrade | JP Morgan | Neutral → Underweight |
| 2019-11-07 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2019-07-22 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2019-07-11 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2019-07-08 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2019-06-11 | Iniziato | Barclays | Equal Weight |
| 2019-05-21 | Aggiornamento | Raymond James | Mkt Perform → Strong Buy |
| 2019-03-20 | Iniziato | SunTrust | Buy |
| 2019-03-08 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2018-12-14 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2018-10-16 | Downgrade | SunTrust | Buy → Hold |
| 2018-08-13 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2018-07-23 | Iniziato | Morgan Stanley | Overweight |
| 2018-06-22 | Iniziato | B. Riley FBR, Inc. | Buy |
Mostra tutto
Amneal Pharmaceuticals Inc Borsa (AMRX) Ultime notizie
Brekiya Migraine Autoinjector Launch Could Be a Game Changer for Amneal Pharmaceuticals (AMRX) - Yahoo Finance
Will Amneal Pharmaceuticals Inc. stock reach Wall Street targets2025 Big Picture & Free Daily Entry Point Trade Alerts - newser.com
Does Amneal Pharmaceuticals Inc. show high probability of rebound2025 Buyback Activity & Fast Gain Swing Alerts - newser.com
Is Amneal Pharmaceuticals Inc. stock resilient to inflationMarket Volume Summary & Technical Pattern Alert System - newser.com
Can Amneal Pharmaceuticals Inc. stock beat market expectations this quarterEarnings Risk Summary & High Accuracy Trade Alerts - Fundação Cultural do Pará
Is Amneal Pharmaceuticals Inc. stock a top momentum playTrade Entry Report & Short-Term Trading Opportunity Alerts - newser.com
How high can Amneal Pharmaceuticals Inc. stock go2025 Earnings Impact & AI Enhanced Trading Signals - newser.com
Will Amneal Pharmaceuticals Inc. stock benefit from automationWeekly Trade Report & Safe Capital Growth Trade Ideas - newser.com
How Amneal Pharmaceuticals Inc. stock compares to industry benchmarksWeekly Trend Report & Free Long-Term Investment Growth Plans - Fundação Cultural do Pará
How to manage a losing position in Amneal Pharmaceuticals Inc.Earnings Overview Report & Fast Gaining Stock Strategy Reports - newser.com
Mycophenolate Pregnancy Registry: Key Insights for Investors - TipRanks
What analyst consensus says on Amneal Pharmaceuticals Inc. stockWeekly Trend Summary & Low Risk High Win Rate Stock Picks - newser.com
Why Amneal Pharmaceuticals Inc. stock could outperform in 2025Market Growth Report & Free Weekly Chart Analysis and Trade Guides - Fundação Cultural do Pará
Amneal Launches Brekiya®the First and Only DHE Autoinjector for Adults with Migraine With or Without Aura and Cluster Headaches - The Manila Times
Candlestick signals on Amneal Pharmaceuticals Inc. stock todayJuly 2025 Snapshot & Free Real-Time Market Sentiment Alerts - newser.com
Amneal (NASDAQ: AMRX) launches Brekiya for migraine, exclusive at Walgreens and Sterling - Stock Titan
Published on: 2025-10-27 03:37:22 - newser.com
Published on: 2025-10-26 15:52:31 - newser.com
Amneal Pharmaceuticals Inc Azioni (AMRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.30%
0.90%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):